Stay updated on Oral GLP1RA in Type 2 Diabetes Clinical Trial
Sign up to get notified when there's something new on the Oral GLP1RA in Type 2 Diabetes Clinical Trial page.

Latest updates to the Oral GLP1RA in Type 2 Diabetes Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedFooter updates include adding 'Revision: v3.3.3' and removing the 'HHS Vulnerability Disclosure' link and 'Revision: v3.3.2' text.SummaryDifference0.2%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check30 days agoChange DetectedRevision history now shows an added Revision: v3.3.2 and removal of Revision: v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check37 days agoChange DetectedRecord History now lists Revision: v3.3.1 as an addition and removes Revision: v3.2.0 from the list.SummaryDifference0.1%

- Check44 days agoChange DetectedA site-wide funding/operating status notice was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check58 days agoChange DetectedThe history shows multiple version updates with changes to Recruitment Status and Study Status, culminating in termination due to financial constraint, indicating the trial is no longer active.SummaryDifference0.1%

- Check87 days agoChange DetectedKey updates: version bump to v3.2.0 and an important government-operating-status notice; the previous v3.1.0 reference was removed. Overall, user-facing status and versioning information were updated. If no other content changed, this is a targeted update to status and versioning.SummaryDifference13%

Stay in the know with updates to Oral GLP1RA in Type 2 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Oral GLP1RA in Type 2 Diabetes Clinical Trial page.